Question 1

Can adults present with dactylitis?

Dr. Sukriti Gupta · Accepted Answer

Dactylitis, swelling of the fingers from small vessel blockage in the hands, is more commonly seen in children because they have not yet developed collateral blood vessels the way adults have. In adults, the vessels involved are relatively larger and better able to develop collaterals, so dactylitis is much less common in that age group.

Question 2

For a positive diagnosis, is the hemoglobin S level the same across all countries?

Dr. Sukriti Gupta · Accepted Answer

Patients carrying both sickle cell genes typically have a haemoglobin S level above 60%, and below that the manifestations are usually milder, seen more in sickle cell trait or a combination haemoglobinopathy such as HbSC or HbSE. There is a general tendency for higher HbS to mean more symptoms, but the correlation is not exact and cannot be relied on mathematically for any individual patient.

Question 3

What types of stroke are sickle cell patients most likely to suffer from, and how can it be prevented?

Dr. Sukriti Gupta · Accepted Answer

The middle and posterior cerebral artery territories are affected most commonly, similar to the pattern seen in adults, though the anterior territory can occasionally be involved too. Regular transcranial Doppler screening from two years of age is the key prevention tool: it uses ultrasound to measure blood flow velocity in the cerebral vessels and identifies children at higher risk of stroke early, so that preventive medication and closer monitoring can begin before a stroke actually happens.

Question 4

What is your comment on the use of hydroxyurea in pregnancy, and what are the alternative options?

Dr. Sukriti Gupta · Accepted Answer

In pregnant women who have generally done well and had infrequent pain crises up to childbearing age, hydroxyurea is usually held during pregnancy since it is not a good option for fetal development. Good hydration and avoiding any other stressful conditions are advised instead, and folic acid supplementation must continue.

Question 5

At what age do we commence hydroxyurea?

Dr. Sukriti Gupta · Accepted Answer

As early as the disease is detected, sometimes as young as two months of age.

Question 6

What is the upper age limit for bone marrow transplant, and what are the cost implications for full match versus half match donors?

Dr. Sukriti Gupta · Accepted Answer

The best outcomes are under 16 years, 16 to 25 is still viable, and beyond 25 the risks rise and require much more detailed pre-transplant workup, including cardiac and kidney function assessment, though age is not always a fixed barrier if organ function is well preserved and the family is fully committed. A full-match sibling transplant typically costs around $24,000 to $25,000, rising for older patients closer to adult body weight, while a half-match or unrelated-donor transplant through a registry costs around $33,000 to $34,000, since registry and donor-related costs are higher even though complications are reduced.

Question 7

In terms of treatment, how is gene therapy done, and is it possible for all patients?

Dr. Sukriti Gupta · Accepted Answer

Gene therapy uses the patient's own stem cells rather than a donor, mobilised and collected the same way as for a transplant, then modified in a laboratory using either a viral vector for gene addition or CRISPR-Cas9 editing to correct the underlying genetic change, a process that currently takes around six months. Because the cells being returned are the patient's own, recovery is generally faster than with a donor transplant, but the therapy currently has FDA approval only for patients aged 12 and older, and it remains expensive and not yet widely available outside the US, Europe and a handful of other countries.

Question 8

In developing countries where finances are a barrier for most families, would you recommend gene therapy or bone marrow transplant?

Dr. Sukriti Gupta · Accepted Answer

If finances are genuinely not a barrier, gene therapy is worth choosing once it is better established, since it avoids the donor-related risks. But where finances are a limiting factor, an experienced allogeneic bone marrow transplant programme should still be trusted: it has decades of mature outcome data behind it, and families should not exhaust all their resources chasing a gene therapy process that could stall partway through. If a patient is having an acute crisis such as a recent stroke, there is also often not enough time to wait the six to eight months gene therapy currently requires, and transplant should be pursued instead.

Question 9

Are biological parents automatically half-match donors, and what are the realistic chances of finding a match within the immediate family?

Dr. Sukriti Gupta · Accepted Answer

Parents are usually a half match by default, provided they are not sicklers themselves and have no disqualifying condition such as HIV or organ damage. A full-match sibling occurs in about 25% of cases, and a half-matched sibling is actually a better donor than a half-matched parent, since sibling cells are better tolerated with fewer pre-existing antibody reactions. Beyond parents and siblings, more distant relatives such as aunts, uncles or cousins are rarely even a half match, so realistic donor availability is mostly limited to the immediate family.

Diagnosis and Management of Sickle Cell Disease

Questions Doctors Asked Dr. Sukriti Gupta